Departamento de Medicina Nuclear


Dra. Martha Pedraza López

(55) 5487-0900 Ext.2402
martha.pedrazal@incmnsz.mx

GRADO ACADÉMICO: Doctorado
CATEGORÍA: Investigador en Ciencias Médicas C
SISTEMA NACIONAL DE INVESTIGADORES Nivel II

 

LINEAS DE INVESTIGACIÓN

Desarrollo de radiofármacos diagnósticos y terapéuticos.

Métodos de laboratorio para evaluar radiofármacos terapéuticos (modelos celular y murino).

Gammagrafía clínica con nuevos radiofármacos.


PUBLICACIONES RELEVANTES DE LOS ULTIMOS 5 AÑOS

V. Lopez-Rodriguez, R.E. Gaspar-Carcamo, M. Pedraza-Lopez, C. Arteaga de Murphy, G. Ferro-Flores, M.A. Avila-Rodriguez Preparation and preclinical evaluation of 66Ga-DOTA-E(c(RGDfK))2 as a Potential theranostic radiopharmaceutical .. Nucl. Med. Biol. 42(2): 109-114 (2015).

Correa-Gonzalez Luis, Arteaga de Murphy Consuelo, Pichardo-Romero Pablo, Pedraza-Lopez Martha, Moreno-Garcia Claudia, Correa-Hernandez Luis. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer. Arch Med Res 45:301-308. (20J4).

A. Vilchis-Juarez, G. Ferro-Flores, C. Santos-Cuevas, Enrique Morales-Avila, Blanca Ocampo-Garcia, Lorenza Diaz-Nieto, M. Luna-Gutiérrez, N. Jiménez-Mancilla, M. Pedraza-López, L. Gómez-Olivan. Molecular Targeting Radiotherapy with cyclo-RGDfK(C) Peptides Conjugated to (177)Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice. J. Biomed. Nanotechnol 10(3) 393-404 (2014).

E. Hardy-Pérez, E. Torres-Garcia, C. Arteaga-de Murphy, M. Pedraza-Lfi pez, E. Mitsoura, N.O. Hernandez-Herrera, K. Isaac-Olivé. Preliminary clinical experience of the systemic use of 153Sm- EDTMP as a pain palliation agent in arthrosis and as an option for bone scanning in patients with bone metastases Revista de Medicina e Investigación 1(2): 50-57. (2013).

V. López-Rodriguez, R.E. Gaspar-Carcamo, V.M. Lara-Camacho, M. Avila-Garcia, G. Ferro-Flores, M. Pedraza-López, C. Arteaga de Murphy, M.A. Avila-Rodriguez, 66Ga labeled DOTA-E-(c(RGDfK))2 and NODAGA-E-(c(RGDfK))2 to target tumors over-expressing nv)3 integrin receptors, J Label Compd Radiopharm 56, S356 (2013).

Nallely Jiménez-Mancilla, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Mirna Luna-Gutiérrez, Flor De Maria Ramirez, Martha Pedraza-López, Eugenio Torres-Garcia. Multifunctional Targeted Radiotherapy System for Induced Tumours Expressing Gastrin-releasing Peptide Receptors. Current Nanoscience (2012) 8: 193-201.

Hardy-Pérez AE, Torres-García E, Arteaga-de-Murphy C, Pedraza-López M, Mitsoura E, Jiménez- Mancilla NP. (153)Sm-HM for arthritic knee pain. Estimated dosimetry. Australas Phys Eng Sci Med. 2012,• 35(I):63-69. ISSN: 8208130.

Sepulveda-Méndez J, Arteaga de Murphy C, Pedraza-López M. Rojas-Bautista JC, Gonzalez-Trevino O. Specificity and sensitivity of”‘tc-edda/hynic-tyr’-octreotide (”'°Tc-TOC) for imaging neuroendocrine tumors. Nuclear Medicine Communications (2012) 33:69-79.

Clara L. Santos-Cuevas, Guillermina Ferro-Flores, Eva L. Rojas-Calderon, Rocio Garcia-Becerra, David Ordaz-Rosado, Consuelo Arteaga de Murphy, Martha Pedraza-López. ”*Tc-N2S2-Tat(49-57)- bombesin Internalised in Nuclei of Prostate and Breast Cancer Cells: Kinetics, Dosimetry and Effect on Cellular Proliferation Nuclear Medicine Communications (2011) 52:303-311.

B.E. Ocampo-Garcia, F. de M. Ramirez, G. Ferro-Flores, L.M. De Leon-Rodríguez, C.L. Santos-Cuevas, E. Morales-Avila, C. Arteaga de Murphy, M. Pedraza-López, L.A. Medina, M.A.Camacho- Lfi pez, 99 Tc-labelled gold nanoparticles capped with HYNlC-peptide/mannose for sentinel lymphnode detection. Nuclear Medicine and Biology (2011) 38:I-11.



Departamento de Medicina Nuclear